[CAS NO. 1174046-72-0]  BMS-794833

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1174046-72-0]

Catalog
SLK-S2201
Brand
Selleck
CAS
1174046-72-0

DESCRIPTION [1174046-72-0]

Overview

MDLMFCD18206786
Molecular Weight468.84
Molecular FormulaC23H15ClF2N4O3
SMILES-

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.1329 mL10.6646 mL21.3292 mL
5 mM0.4266 mL2.1329 mL4.2658 mL
10 mM0.2133 mL1.0665 mL2.1329 mL
50 mM0.0427 mL0.2133 mL0.4266 mL

Description

BMS-794833 is a potent ATP competitive inhibitor of with of 1.7 nM/15 nM, also inhibits Ron, Axl and Flt3 with IC50 of <3 nM; a prodrug of BMS-817378. Phase 1.

Targets

Met [1]VEGFR2 [1]
1.7 nM15 nM

In vitro

BMS794833 also inhibits Met receptor activated gastric carcinoma cell line, GTL-16, with IC50 of 39 nM.

In vivo

In GTL-16 human gastric tumor xenografts model, BMS798433 shows greater than 50% TGI for at least one tumor doubling time with no overt toxicity observed during 14 days. BMS798433 also shows complete tumor stasis at a dose of 25 mg/kg against U87 glioblastoma model.